Linda.Bunschoten

About Linda Bunschoten - Chief Marketing Officer

Linda has 25+ years of experience uncovering pain points and strategizing with companies in the healthcare industry in order to secure and retain more clients. Her chief thinking responsibilities include translating insight into strategy and ensure that all MarCom and Product Management activities contribute to our overall customer experience and meet our industry’s quality expectations.
Mar 2020

Cyntegrity Amongst Companies Fighting Back the COVID-19 Outbreak

By |2020-03-23T13:48:08+02:00March 23, 2020|News|Comments Off on Cyntegrity Amongst Companies Fighting Back the COVID-19 Outbreak

Frontiers Health Ecosystem Companies Fighting Back the COVID-19 Outbreak As the COVID-19 outbreak continues, it has become even more challenging for patients to seek in- person medical care and for healthcare providers (HCP) to guarantee community health services for people who may have symptoms [...]

Mar 2020

Coronavirus | COVID-19 RACT Now Available

By |2022-07-21T12:15:31+02:00March 20, 2020|Neat Features, News, RBQM Product Updates|Comments Off on Coronavirus | COVID-19 RACT Now Available

Cyntegrity developed a special COVID-19 RACT that guides those involved in clinical trials on specific risks which may arise as a result of COVID-19, and how they can mitigate them. This special RACT is part of the COVID-19 rapid deployment pack for ad-hoc centralized monitoring.

Mar 2020

Coronavirus | What if you can no longer visit your sites?

By |2024-11-25T18:19:38+02:00March 6, 2020|Blog|Comments Off on Coronavirus | What if you can no longer visit your sites?

We can help establish near real-time centralized monitoring, enable the use of "ad-hoc crisis management" Key Risk Indicators (KRIs), and mitigate patient safety and study quality risks.

Mar 2020

Best Case Studies for RBQM | Merz Pharma’s RBQM Journey

By |2020-11-03T14:50:45+02:00March 5, 2020|Case Studies, News|Comments Off on Best Case Studies for RBQM | Merz Pharma’s RBQM Journey

This week Applied Clinical Trials published an interesting case study of the risk-based quality management learning curve. The provision of a set of training modules helped Merz Pharma to initiate a smooth RBQM rollout.

Feb 2020

Indication Focused RBQM for Rare Disease Drug Development

By |2020-02-28T08:30:17+02:00February 28, 2020|Blog|Comments Off on Indication Focused RBQM for Rare Disease Drug Development

Adaptive and intelligent Risk Based Quality Management (RBQM) is a powerful strategy for rare disease research. One of the main benefits is that RBQM allows for patient-centric trial design that is uniquely tailored to the specific rare disease.

Feb 2020

Healthy Volunteers – Phase 1 RACT Now Available

By |2024-07-31T15:50:55+02:00February 11, 2020|Neat Features, News, Phase 1 - FIH, RBQM Product Updates|Comments Off on Healthy Volunteers – Phase 1 RACT Now Available

The need for a controlled research environment adds another risk dimension to the Phase 1 study design. The new Healthy Volunteers - Phase 1 RACT serves as a helpful source to ensure maximum subject safety and a reliable outcome.

Jan 2020

MERZ Pharma Chose Cyntegrity’s MyRBQM® Academy for Educating Their Staff

By |2020-01-28T10:19:40+02:00January 28, 2020|News|Comments Off on MERZ Pharma Chose Cyntegrity’s MyRBQM® Academy for Educating Their Staff

Cyntegrity proudly welcomes MERZ Pharma to its MyRBQM Academy Alumni community! Established in 2019, Cyntegrity's MyRBQM® Academy, unites comprehensive online education, instructor-led classroom training and practical case study workshops.

Dec 2019

Release Notes | MyRBQM® Portal Version 6.0.8

By |2020-09-23T10:43:36+02:00December 19, 2019|News, RBQM Product Updates|Comments Off on Release Notes | MyRBQM® Portal Version 6.0.8

MyRBQM Portal V6.0.8 has released! We're constantly working to improve your Risk-Based Quality Management experience, here's a summary of what has changed.

Go to Top